Search for: "Sanofi"
Results 81 - 100
of 1,187
Sort by Relevance
|
Sort by Date
9 Jul 2023, 8:40 pm
Sanofi regarding the sufficiency of disclosure needed to satisfy the statutory enablement requirement under 35 US.C. [read post]
3 Jul 2023, 3:00 am
Sanofi to require that the full scope of the claims must be enabled. [read post]
26 Jun 2023, 6:59 am
This version of insulin is expected to be interchangeable with popular brand-name insulins – Sanofi’s Lantus, Eli Lilly’s Humalog and Novo Nordisk’s Novolog. [read post]
26 Jun 2023, 3:38 am
The patents concerned are the same patent family that was successfully challenged before the US Supreme Court in Amgen v Sanofi, which you can read about here from Rose Hughes. [read post]
22 Jun 2023, 4:45 am
Sanofi upholds the Federal Circuit’s longstanding requirement to enable the full scope of a claimed invention. [read post]
22 Jun 2023, 4:45 am
Sanofi upholds the Federal Circuit’s longstanding requirement to enable the full scope of a claimed invention. [read post]
21 Jun 2023, 4:05 pm
Sanofi, the implications of artificial intelligence (AI) for patenting, and ethics pitfalls practitioners may face as a result of AI use. [read post]
21 Jun 2023, 4:05 pm
Sanofi, the implications of artificial intelligence (AI) for patenting, and ethics pitfalls practitioners may face as a result of AI use. [read post]
15 Jun 2023, 2:20 pm
., Sanofi-Aventis Deutschland GmbH v. [read post]
10 Jun 2023, 4:02 pm
This approach is consistent with existing case law.Rose mentioned that the recent US Supreme Court decision Amgen v Sanofi (No. 21-757) was also a good decision. [read post]
9 Jun 2023, 8:20 am
Sanofi for patents come to mind – the Jack Daniel’s court is much more assertive than it usually is in this area in offering bold and unqualified basic principles as a basis for its decision. [read post]
31 May 2023, 9:43 am
Amgen sued Sanofi for infringement and Sanofi counterclaimed that Amgen's patents were invalid for lack of enablement. [read post]
26 May 2023, 2:23 pm
Sanofi as an “endorsement of the Federal Circuit’s current interpretation and application of the enablement requirement, and maintenance of the status quo. [read post]
25 May 2023, 6:00 am
In Sanofi-Aventis Deutschland GMBH v. [read post]
23 May 2023, 2:37 pm
Sanofi, including Dennis’s prompt response. [read post]
22 May 2023, 4:59 pm
Sanofi, et al., No. 21-757. [read post]
22 May 2023, 1:30 pm
Sanofi on Thursday, holding that the U.S. [read post]
22 May 2023, 1:30 pm
Sanofi on Thursday, holding that the U.S. [read post]
19 May 2023, 4:03 pm
Sanofi. [read post]
19 May 2023, 11:15 am
This week in Other Barks & Bites: Sanofi wins its patent case against Amgen in front of the U.S. [read post]
